Mold maker IGS GeboJagema moves part of the production to Brainport Industries Campus

By Team IO

If there is one aspect of importance in the high-tech manufacturing industry, it is the extreme precision with which machines are built. Eindhoven-based IGS GeboJagema has made that its trademark. Inhalers, insulin pens, and contact lenses are all products that are produced in high volumes and with enormous precision, thanks to IGS GeboJagema’s molds. IGS is a global role model in the design, machining, production, qualification, and maintenance of injection molds for the optical, healthcare, and packaging industries.

The ever-growing demand for these types of molds worldwide has made the expansion of IGS’ production capacity necessary. Brainport Industries Campus (BIC) fortunately offers a solution. In October, IGS GeboJagema will move into one of the last available spaces in cluster 1 of the campus. This involves the first part of the production process: the pre-processing of parts for the molds. For now, the follow-up steps will remain in nearby Esp, Eindhoven.

Perfect location

CEO Herman Rusch calls BIC “the perfect location”: close to the headquarters and equipped with all necessities. “And also with the guarantee of an uninterrupted power supply for the coming years as well, which is no longer a matter of course in these times.” Although the market for IGS is global, the company feels a solid connection to Brainport regarding its ecosystem and talent recruitment. “At Brainport Industries Campus, you can just walk into everyone’s office, including Summa and Fontys as educators. For our employer branding that is ideal, just like for attracting the right craftsmanship.”

Rusch emphasizes that his company can also benefit other campus residents. “Our experience around Industry 4.0 can be an inspiration for many others. The ASML ecosystem is a huge source of knowledge, and we play our part in that as well.” The extremely accurate sizing IGS uses in its production processes makes the company an ambassador for the high-tech manufacturing industry for which Brainport Eindhoven is so well known. This also makes IGS the ideal new tenant for BIC.

Cluster 2

Ferdinand Gremmen, director of SDK Vastgoed and responsible for BIC: “That a world player like IGS GeboJagema chooses Brainport Industries Campus shows the role we now play in this high-tech ecosystem. We are proud to help this great company solve its expansion plans and make them part of our relevant network in the manufacturing industry. IGS expects even more growth in the coming years – we are also prepared for that: if it would no longer be possible in cluster 1, then certainly in time in cluster 2.”

Although the lens branch of IGS also shows annual growth of about 6%, IGS’s growth expectations are increasingly based on the production of molds for inhalers and insulin pens, which now account for half of total sales. Rusch: “The orders are going so fast that we expect to at least double our €40 million turnover in the next few years. The three largest pharmaceutical companies operating in this market are among our customers, so we are well prepared with this move to BIC.”